BA
ORKA

BlackRock Advisors’s Oruka Therapeutics ORKA Stock Holding History

BlackRock Advisors’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-7
Closed -$15K – 3724
2014
Q2 		$15K Buy
7
+3
+75% +$6.98K ﹤0.01% 3518
2014
Q1 		$10K Hold
4
– – ﹤0.01% 3542
2013
Q4 		$9K Buy
4
+2
+100% +$4.62K ﹤0.01% 3519
2013
Q3 		$5K Hold
2
– – ﹤0.01% 3555
2013
Q2 		$4K Buy
+2
New +$6.11K ﹤0.01% 3536

Other funds holding ORKA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $126M AUM 15.32% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BlackRock Advisors's ORKA Position: Q3 2014 in Review

BlackRock Advisors sold out of Oruka Therapeutics (ORKA) in Q3 2014, closing a stake of 7 shares — an estimated $15K sold.

BlackRock Advisors first reported a position in ORKA in Q2 2013 and held it in 5 quarters. The position peaked at $15K in Q2 2014. 15 funds tracked by Wall St. Rank hold ORKA as of Q3 2014.

  • BlackRock Advisors reported no remaining Oruka Therapeutics position as of Q3 2014 after selling out during the quarter.
  • BlackRock Advisors sold 7 Oruka Therapeutics shares in Q3 2014, an estimated $15K.
  • BlackRock Advisors first reported a position in Oruka Therapeutics in Q2 2013 and held it in 5 quarters.
  • BlackRock Advisors's Oruka Therapeutics position peaked at $15K in Q2 2014.
  • 15 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2014.

Based on BlackRock Advisors's 13F filing for Q3 2014, filed 29 Oct 2014.